CAROL COPELIN: Open Payments
NPI 1669637831 · BRECKENRIDGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$141 in 7 payments from 7 companies in 2025. Trend: 2023 $286 · 2024 $246 · 2025 $141
Food & beverage: $141
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: INGREZZA, VRAYLAR, AUSTEDO XR, AIRSUPRA, JARDIANCE, M-M-R II.
Industry payments across TX — which companies pay providers there.
